1. Li, X, Liu, Y, Lv, J, et al. Progression of IgA nephropathy under current therapy regimen in a Chinese population. Clin J Am Soc Nephrol 2014; 9: 484–489.
Google Scholar | Crossref | Medline2. Hassler, JR. IgA nephropathy: a brief review. Semin Diagn Pathol 2020; 37: 143–147.
Google Scholar | Crossref | Medline3. Rodrigues, JC, Haas, M, Reich, HN. IgA nephropathy. Clin J Am Soc Nephrol 2017; 12: 677–686.
Google Scholar | Crossref | Medline4. Zhang, K, Li, Q, Zhang, Y, et al. Clinical significance of galactose-deficient IgA1 by KM55 in patients with IgA nephropathy. Kidney Blood Press Res 2019; 44: 1196–1206.
Google Scholar | Crossref | Medline5. Mao, X, Xu, Z, Xu, X, et al. TGF-beta1 inhibits the autophagy of podocytes by activating mTORC1 in IgA nephropathy. Exp Cell Res 2019; 385: 111670.
Google Scholar | Crossref | Medline6. Mattii, L, Segnani, C, Cupisti, A, et al. Kidney expression of RhoA, TGF-beta1, and fibronectin in human IgA nephropathy. Nephron Exp Nephrol 2005; 101: e16–e23.
Google Scholar | Crossref | Medline7. Premuzic, V, Padjen, I, Cerovec, M, et al. The association of TNF-alpha inhibitors and development of IgA nephropathy in patients with rheumatoid arthritis and diabetes. Case Rep Nephrol 2020; 2020: 9480860.
Google Scholar | Medline8. Suzuki, H, Raska, M, Yamada, K, et al. Cytokines alter IgA1 O-glycosylation by dysregulating C1GalT1 and ST6GalNAc-II enzymes. J Biol Chem 2014; 289: 5330–5339.
Google Scholar | Crossref | Medline9. Taniguchi, Y, Yorioka, N, Kumagai, J, et al. Interleukin-6 localization and the prognosis of IgA nephropathy. Nephron 1999; 81: 94–98.
Google Scholar | Crossref | Medline10. Lin, Y, Jia, J, Guo, Y, et al. Corticosteroid for IgA nephropathy: are they really therapeutic? Am J Nephrol 2018; 47: 385–394.
Google Scholar | Crossref | Medline11. Li, M, Foo, JN, Wang, JQ, et al. Identification of new susceptibility loci for IgA nephropathy in Han Chinese. Nat Commun 2015; 6: 7270.
Google Scholar | Crossref | Medline12. Shi, M, Ouyang, Y, Yang, M, et al. IgA nephropathy susceptibility loci and disease progression. Clin J Am Soc Nephrol 2018; 13: 1330–1338.
Google Scholar | Crossref | Medline13. Liu, Y, Wang, F, Zhang, Y, et al. ST6Gal1 is up-regulated and associated with aberrant IgA1 glycosylation in IgA nephropathy: an integrated analysis of the transcriptome. J Cell Mol Med 2020; 24: 10493–10500.
Google Scholar | Crossref | Medline14. Barb, AW, Brady, EK, Prestegard, JH. Branch-specific sialylation of IgG-Fc glycans by ST6Gal-I. Biochemistry 2009; 48: 9705–9707.
Google Scholar | Crossref | Medline15. Pagan, JD, Kitaoka, M, Anthony, RM. Engineered sialylation of pathogenic antibodies in vivo attenuates autoimmune disease. Cell 2018; 172: 564–577.
Google Scholar | Crossref | Medline16. Engdahl, C, Bondt, A, Harre, U, et al. Estrogen induces St6gal1 expression and increases IgG sialylation in mice and patients with rheumatoid arthritis: a potential explanation for the increased risk of rheumatoid arthritis in postmenopausal women. Arthritis Res Ther 2018; 20: 84.
Google Scholar | Crossref | Medline17. Gudelj, I, Salo, PP, Trbojevic-Akmacic, I, et al. Low galactosylation of IgG associates with higher risk for future diagnosis of rheumatoid arthritis during 10years of follow-up. Biochim Biophys Acta Mol Basis Dis 2018; 1864: 2034–2039.
Google Scholar | Crossref | Medline18. Alavi, A, Arden, N, Spector, TD, et al. Immunoglobulin G glycosylation and clinical outcome in rheumatoid arthritis during pregnancy. J Rheumatol 2000; 27: 1379–1385.
Google Scholar | Medline19. Wang, J, Xie, P, Huang, JM, et al. The new Asian modified CKD-EPI equation leads to more accurate GFR estimation in Chinese patients with CKD. Int Urol Nephrol 2016; 48: 2077–2081.
Google Scholar | Crossref | Medline20. Trimarchi, H, Barratt, J, Cattran, DC, et al. Oxford classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group. Kidney Int 2017; 91: 1014–1021.
Google Scholar | Crossref | Medline21. Hayashi, K, Takayama, M, Abe, T, et al. Investigation of metabolic factors associated with eGFR decline over 1 year in a Japanese Population WITHOUT CKD. J Atheroscler Thromb 2017; 24: 863–875.
Google Scholar | Crossref | Medline22. Fu, D, Zhong, Z, Shi, D, et al. ST6GAL1 polymorphisms influence susceptibility and progression of IgA nephropathy in a Chinese Han population. Immunobiology 2020; 225: 151973.
Google Scholar | Crossref | Medline23. Thompson, A, Carroll, K, Inker, LA, et al. Proteinuria reduction as a surrogate end point in trials of IgA nephropathy. Clin J Am Soc Nephrol 2019; 14: 469–481.
Google Scholar | Crossref | Medline24. Lee, TW, Ahn, JH, Park, JK, et al. Tumor necrosis factor alpha from peripheral blood mononuclear cells of IgA nephropathy and mesangial cell proliferation. Korean J Intern Med 1994; 9: 1–8.
Google Scholar | Crossref | Medline25. Anthony, RM, Ravetch, JV. A novel role for the IgG Fc glycan: the anti-inflammatory activity of sialylated IgG Fcs. J Clin Immunol 2010; 30(Suppl. 1): S9–S14.
Google Scholar | Crossref | Medline26. Wong, AH, Fukami, Y, Sudo, M, et al. Sialylated IgG-Fc: a novel biomarker of chronic inflammatory demyelinating polyneuropathy. J Neurol Neurosurg Psychiatry 2016; 87: 275–279.
Google Scholar | Crossref | Medline27. Ohmi, Y, Ise, W, Harazono, A, et al. Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis. Nat Commun 2016; 7: 11205.
Google Scholar | Crossref | Medline28. Bartsch, YC, Rahmoller, J, Mertes, MMM, et al. Sialylated autoantigen-reactive IgG antibodies attenuate disease development in autoimmune mouse models of lupus nephritis and rheumatoid arthritis. Front Immunol 2018; 9: 1183.
Google Scholar | Crossref | Medline29. Troelsen, LN, Jacobsen, S, Abrahams, JL, et al. IgG glycosylation changes and MBL2 polymorphisms: associations with markers of systemic inflammation and joint destruction in rheumatoid arthritis. J Rheumatol 2012; 39: 463–469.
Google Scholar | Crossref | Medline30. Maixnerova, D, Ling, C, Hall, S, et al. Galactose-deficient IgA1 and the corresponding IgG autoantibodies predict IgA nephropathy progression. PLoS One 2019; 14: e212254.
Google Scholar31. Moldoveanu, Z, Suzuki, H, Reily, C, et al. Experimental evidence of pathogenic role of IgG autoantibodies in IgA nephropathy. J Autoimmun 2021; 118: 102593.
Google Scholar | Crossref | Medline